Opposite regulation of interleukin-8 and tumor necrosis factor-α by weight loss

Obesity Research

Volumn 10, Issue 6, 2002, Pages 499-506

  Bruun, Jens M ^a   Pedersen, Steen B ^a   Kristensen, Kurt ^a   Richelsen, Bjørn ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Human adipose tissue; Interleukin 8; Obesity related health complications; Tumor necrosis factor ; Weight loss

Indexed keywords

INSULIN; INTERLEUKIN 8; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOPSY; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; CULTURE TECHNIQUE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BIOPSY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; CULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INTERLEUKIN-8; LEPTIN; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 0036614943     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.68     Document Type: Article

References (36)

1. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease. Curr Opin Cardiol. 1996;11:490-5.
2. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am Clin Nutr. 1997;66:1044S-1050S.
3. Anonymous. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med. 2000;160:898-904.
4. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int Obes Relat Metab Disord. 1998;22:1145-58.
5. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11:327-32.
6. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl Med. 1996;334:292-5.
7. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83:2907-10.
8. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41:65-71.
9. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85:3338-42.
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-15.
11. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43-52.
12. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J. Effects of tumour necrosis factor α (TNF α) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 1995;38:764-71.
13. Sethi JK, Hotamisligil GS. The role of TNF α in adipocyte metabolism. Semin Cell Dev Biol. 1999;10:19-29.
14. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am Physiol Endocrinol Metab. 2001;280:E745-E751.
15. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:859-62.
16. Schreyer SA, Chua SCJ, LeBoeuf RC. Obesity and diabetes in TNF-α receptor-deficient mice. J Clin Invest. 1998;102: 402-11.
17. Koistinen HA, Bastard JP, Dusserre E, et al. Subcutaneous adipose tissue expression of tumour necrosis factor-α is not associated with whole body insulin resistance in obese non-diabetic or in type-2 diabetic subjects. Eur Clin Invest. 2000; 30:302-10.
18. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int Immunopharmacol. 1995;17:103-8.
19. Bruun JM, Pedersen SB, Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab. 2001;86:1267-73.
20. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001;175:81-92.
21. Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res. 1999;19:429-38.
22. Yue TL, Mckenna PJ, Gu JL, Feuerstein GZ. Interleukin-8 is chemotactic for vascular smooth muscle cells. Eur Pharmacol. 1993;240:81-4.
23. Liu Y, Hulten LM, Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol. 1997;17:317-23.
24. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M. Interleukin-8 mediates down-regulation of tissue inhibitor of metalloproteinasc-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation. 1999;99:420-6.
25. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis. 1999;147:213-25.
26. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia. 1999;42:117-8.
27. Heitmann BL. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int Obes. 1990;14:789-802.
28. Pedersen SB, Borglum J, Jorgensen JO, Richelsen B. Growth Hormone Treatment of Obese Premenopausal Women: Effects on Isolated Adipocyte Metabolism. Endocrinol Metab. 1995;251-8.
29. Kristensen K, Pedersen SB, Richelsen B. Regulation of leptin by steroid hormones in rat adipose tissue. Biochem Biophys Res Commun. 1999;259:624-30.
30. He G, Pedersen SB, Bruun JM, Richelsen B. Regulation of plasminogen activator inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen. Horm Metab Res. 2000;32:515-20.
31. O'Brien SN, Mantzke KA, Kilgore MW, Price TM. Relationship between adipose stromal-vascular cells and adipocytes in human adipose tissue. Anal Quant Cytol Histol. 1996;18:137-43.
32. Bruun JM, Pedersen SB, Richelsen B. Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitizone and the biguanide metformin. Horm Metab Res. 2000;32:537-41.
33. Baldwin AS. Series introduction: the transcription factor NF-κB and human disease. J Clin Invest. 2001:107:3-6.
34. Friedland JS. Chemokines in viral disease. Res Virol. 1996; 147:131-8.
35. De Benedetti F, Pignatti P, Bernasconi S, et al. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol. 1999;26:425-31.
36. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6. but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997;82:4196-200.